
Cancer Precursor Conditions and their Detection, An Issue of Hematology/Oncology Clinics of North America
- 1st Edition, Volume 38-4 - July 4, 2024
- Imprint: Elsevier
- Editor: Elizabeth K. O'Donnell
- Language: English
- Hardback ISBN:9 7 8 - 0 - 4 4 3 - 2 9 3 5 0 - 4
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 2 9 3 5 1 - 1
In this issue of Hematology/Oncology Clinics, guest editor Dr. Elizabeth K. O'Donnell brings her considerable expertise to the topic of Cancer Precursor Syndromes and Their Det… Read more

Purchase options

Institutional subscription on ScienceDirect
Request a sales quoteIn this issue of Hematology/Oncology Clinics, guest editor Dr. Elizabeth K. O'Donnell brings her considerable expertise to the topic of Cancer Precursor Syndromes and Their Detection. Top experts focus on cancer precursors for different sites, with articles on the risk-benefit analysis of early interception; plasma cell precursors; early detection and interception of lung cancer, cervical cancer, GI cancers, skin cancer; and head and neck cancer; biomarkers and early detection; and more.
- Contains 12 relevant, practice-oriented topics including clonal hematopoiesis of indeterminate potential (CHIP); prostate cancer: early detection and intervention; ductal carcinoma in situ; cancer prevention; and more.
- Provides in-depth clinical reviews on cancer precursor syndromes and their detection, offering actionable insights for clinical practice.
- Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Oncology, hematology
- Cover image
- Title page
- Table of Contents
- Copyright
- Contributors
- Forthcoming Issues
- Preface
- Benefits and Harms of Interception and Early Detection of Cancer
- Key points
- Introduction
- Mapping benefits and harms
- Factors affecting the extent of benefits and harms
- Decision modeling
- Limitations
- Early Detection of Precursor Diseases of Multiple Myeloma
- Key points
- Introduction
- Defining precursor diseases
- Tools for diagnosis
- Risk stratification of precursor diseases
- Screening
- Treatment of precursor diseases
- Summary
- Clinics care points
- Early Detection and Interception of Lung Cancer
- Key points
- Introduction
- The history of lung cancer screening
- Implementation of low-dose computed tomography screening in the United States
- Tobacco use, stigma, race, and updated lung cancer screening guidelines
- Reasons for optimism
- Summary
- Clinics care points
- Cervical Cancer: Precursors and Prevention
- Key points
- Introduction and epidemiology
- Cervical cancer precursors
- Human papillomavirus prophylactic vaccines
- Screening, management, and diagnosis of cervical cancer precursors
- Treatment of cervical cancer precursors
- Discussion
- Clinics care points
- Gastrointestinal Cancer Precursor Conditions and Their Detection
- Key points
- Introduction
- Colorectal cancer predisposition and precursor conditions
- Gastroesophageal cancer predisposition and precursor conditions
- Pancreatic cancer predisposition and precursor conditions
- Summary
- Clinics care points
- Cancer Precursor Syndromes and Their Detection in the Head and Neck
- Key points
- Introduction
- Epidemiology and risk factors
- Hereditary conditions
- Oral potentially malignant disorders
- Molecular and immunologic features
- Therapeutic strategies and cancer prevention drug development
- Clinics care points
- Ductal Carcinoma In Situ
- Key points
- Biology and natural clinical history of ductal carcinoma in situ
- Primary and secondary prevention
- Surgical considerations
- Early detection
- Risk stratification and treatment tailoring strategies
- Skin Cancer Precursors: From Cancer Genomics to Early Diagnosis
- Key points
- Introduction
- The main concepts of skin cancer initiation
- Precursor and progression models
- Cancer immunoediting and immunosuppression
- Skin cancer detection and current screening recommendations
- Summary
- Clinics care points
- Biomarkers in Cancer Screening: Promises and Challenges in Cancer Early Detection
- Key points
- Introduction
- Current screening and early detection modalities
- Types of early lesions
- Early detection biomarkers
- New developments in molecular cancer screening and early detection
- Future directions
- Edition: 1
- Volume: 38-4
- Published: July 4, 2024
- Imprint: Elsevier
- No. of pages: 240
- Language: English
- Hardback ISBN: 9780443293504
- eBook ISBN: 9780443293511
EO
Elizabeth K. O'Donnell
Affiliations and expertise
Assistant Professor of Medicine, Dana-Farber Cancer Institute Boston, MA, USA